These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 23651440

  • 1. The mean fluorescence intensities of anti-HLA antibodies detected using micro-bead flow cytometry predict the risk of platelet transfusion refractoriness.
    Beligaswatte A, Tsiopelas E, Humphreys I, Bennett G, Robinson K, Davis K, Bardy P.
    Br J Haematol; 2013 Aug; 162(3):409-12. PubMed ID: 23651440
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia].
    Uchiyama Y, Hoshino T, Mihara M, Mitsui T, Koiso H, Takizawa M, Yokohama A, Saitoh T, Uchiumi H, Handa H, Tsukamoto N, Murakami H, Nojima Y.
    Rinsho Ketsueki; 2013 Feb; 54(2):214-8. PubMed ID: 23470830
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
    Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC.
    J Surg Res; 2020 Nov; 255():99-105. PubMed ID: 32543385
    [Abstract] [Full Text] [Related]

  • 7. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y.
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alloimmune platelet transfusion refractoriness circumvented by allogeneic stem cell transplantation.
    Bonstein L, Stemer G, Dann EJ, Zuckerman T, Fineman R, Haddad N.
    Transfusion; 2013 May; 53(5):1019-23. PubMed ID: 22897696
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China.
    Xia WJ, Ye X, Tian LW, Xu XZ, Chen YK, Luo GP, Bei CH, Deng J, Santoso S, Fu YS.
    Transfus Med; 2010 Aug 01; 20(4):269-74. PubMed ID: 20136782
    [Abstract] [Full Text] [Related]

  • 17. Routine Solid Phase Multiplex Anti-HLA Antibody Tests Predict Platelet Refractoriness.
    Peña JRA, Makar RS.
    Am J Clin Pathol; 2019 Jul 05; 152(2):146-154. PubMed ID: 31065667
    [Abstract] [Full Text] [Related]

  • 18. Pretransplant platelet transfusion refractoriness is not associated with platelet nonengraftment in T-replete hematopoietic progenitor cell transplantation for hematologic malignancies.
    Scott A, Baidya S, Butler J, Morris K, Thornton A, Kennedy GA.
    Transfusion; 2016 Jan 05; 56(1):164-9. PubMed ID: 26264674
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Platelet transfusion refractoriness attributable to HLA antibodies produced by donor-derived cells after allogeneic bone marrow transplantation from one HLA-antigen-mismatched mother.
    Hatakeyama N, Hori T, Yamamoto M, Inazawa N, Iesato K, Miyazaki T, Ikeda H, Tsutsumi H, Suzuki N.
    Pediatr Transplant; 2011 Dec 05; 15(8):E177-82. PubMed ID: 20880381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.